TRANSPATH
Transglutaminase in disease: a novel therapeutic target?
| Coordinatore | ASTON UNIVERSITY
Organization address
address: ASTON TRIANGLE contact info |
| Nazionalità Coordinatore | United Kingdom [UK] |
| Totale costo | 3˙740˙034 € |
| EC contributo | 3˙740˙034 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2011-ITN |
| Funding Scheme | MC-ITN |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-11-01 - 2015-10-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
ASTON UNIVERSITY
Organization address
address: ASTON TRIANGLE contact info |
UK (BIRMINGHAM) | coordinator | 795˙367.01 |
| 2 |
UNIVERSITETET I OSLO
Organization address
address: Problemveien 5-7 contact info |
NO (OSLO) | participant | 552˙339.00 |
| 3 |
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA
Organization address
address: VIA ORAZIO RAIMONDO 18 contact info |
IT (ROMA) | participant | 504˙971.00 |
| 4 |
STICHTING VU-VUMC
Organization address
address: DE BOELELAAN 1105 contact info |
NL (AMSTERDAM) | participant | 500˙869.00 |
| 5 |
COVALAB SAS
Organization address
address: AVENUE ALBERT EINSTEIN 11 contact info |
FR (VILLEURBANNE) | participant | 265˙091.01 |
| 6 |
UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO
Organization address
address: DUOMO 6 contact info |
IT (VERCELLI) | participant | 256˙903.00 |
| 7 |
X-Link Limited
Organization address
address: "Biocity Nottingham, Pennyfoot Street" contact info |
UK (Nottingham) | participant | 239˙396.00 |
| 8 |
DEBRECENI EGYETEM
Organization address
address: EGYETEM TER 1 contact info |
HU (DEBRECEN) | participant | 211˙419.00 |
| 9 |
UD-GENOMED MEDICAL GENOMIC TECHNOLOGIES KUTATAS-FEJLESZTESI ES SZOLGALTATO KFT
Organization address
address: NAGYERDEI KRT 98 contact info |
HU (DEBRECEN) | participant | 211˙419.00 |
| 10 |
YEDITEPE UNIVERSITY
Organization address
address: Agustos Yerlesimi Kayisdagi Cad. 26 contact info |
TR (Istanbul) | participant | 202˙259.99 |
| 11 |
VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG
Organization address
address: De Boelelaan 1105 contact info |
NL (AMSTERDAM) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'TRANSPATH is a multisectorial Network designed to facilitate the exchange of knowledge and technology between 7 leading European research teams and 3 SME partners and 2 associate SME Partners involved in basic and applied research into transglutaminase (TG) related human diseases. Its ambitions are to accelerate the development of new strategies for the treatment and diagnosis of human diseases related to transglutaminases, including metastatic cancer, neurodegeneration and celiac disease. The subject is highly relevant as deregulation of tissue transglutaminase activity is observed in a number of human diseases while the exact mechanisms are still largely unknown. The project targets this unmet clinical need. The main objectives are :1) to establish the molecular nature of the role of transglutaminases in the pathogenesis of diseases which are known to involve these multifunctional enzymes with a view to developing novel specific inhibitors and new therapeutic approaches which will have a major impact on their treatment ;2) provide an extensive cross sectorial scientific and supporting training network that will increase the capabilities of highly skilled researchers for the European biotechnology industry and academia.'
Altri progetti dello stesso programma (FP7-PEOPLE)
PROTBIOFLUID (2011)
PROTEOMIC IDENTIFICATION OF BIOMARKERS IN BIOFLUIDS AND IN PRECLINICAL MODELS FOR THE EARLY DIAGNOSIS AND PROGNOSIS OF CANCER (PROT*BIO*FLUID)
Read MoreSV-STAPH-VAX (2014)
Structural Vaccinology to drive the design and optimization of protein antigens for a multicomponent vaccine against Staphylococcus aureus
Read More